EMERGENT BIOSOLUTIONS INC. Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred
EMERGENT BIOSOLUTIONS INC. (EBS) reported Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-19.
Discontinued › Notes
us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred · last filed 2021-02-19
- EMERGENT BIOSOLUTIONS INC. business combination, provisional information, initial accounting incomplete, adjustment, consideration transferred for the quarter ending 2019-09-30 was $0.00.
- EMERGENT BIOSOLUTIONS INC. business combination, provisional information, initial accounting incomplete, adjustment, consideration transferred for the quarter ending 2019-06-30 was -$1.50M.
- EMERGENT BIOSOLUTIONS INC. business combination, provisional information, initial accounting incomplete, adjustment, consideration transferred for the quarter ending 2019-03-31 was $1.50M.
- EMERGENT BIOSOLUTIONS INC. business combination, provisional information, initial accounting incomplete, adjustment, consideration transferred for fiscal 2020 was $0.00.
| Period end | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred 3 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred 6 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred 9 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-19 | |||
| 2019-09-30 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2020-02-25 | -$1.50M derived: sum of 2 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | |
| 2019-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $0.00 10-Q · filed 2019-08-02 | ||
| 2019-03-31 | $1.50M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |